Doxorubicin Recruiting Phase 2 Trials for Soft Tissue Sarcoma, Adult / Soft Tissue Sarcoma, Child Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03056001Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma